GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MEI Pharma Inc (LTS:0JW9) » Definitions » Cyclically Adjusted FCF per Share

MEI Pharma (LTS:0JW9) Cyclically Adjusted FCF per Share : $-7.30 (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is MEI Pharma Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

MEI Pharma's adjusted free cash flow per share for the three months ended in Mar. 2025 was $-0.490. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-7.30 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 22.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 29.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 27.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of MEI Pharma was 36.10% per year. The lowest was 11.60% per year. And the median was 23.70% per year.

As of today (2025-05-23), MEI Pharma's current stock price is $2.1244. MEI Pharma's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was $-7.30. MEI Pharma's Cyclically Adjusted Price-to-FCF of today is .


MEI Pharma Cyclically Adjusted FCF per Share Historical Data

The historical data trend for MEI Pharma's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MEI Pharma Cyclically Adjusted FCF per Share Chart

MEI Pharma Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -28.80 -22.03 -13.02 -86.91 -8.53

MEI Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.57 -8.53 -8.21 -7.44 -7.30

Competitive Comparison of MEI Pharma's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, MEI Pharma's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MEI Pharma's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MEI Pharma's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MEI Pharma's Cyclically Adjusted Price-to-FCF falls into.


;
;

MEI Pharma Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MEI Pharma's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.49/134.9266*134.9266
=-0.490

Current CPI (Mar. 2025) = 134.9266.

MEI Pharma Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -3.936 100.684 -5.275
201509 -3.355 100.392 -4.509
201512 -2.457 99.792 -3.322
201603 -2.548 100.470 -3.422
201606 -2.024 101.688 -2.686
201609 4.908 101.861 6.501
201612 -2.013 101.863 -2.666
201703 0.864 102.862 1.133
201706 -1.680 103.349 -2.193
201709 -3.524 104.136 -4.566
201712 -2.539 104.011 -3.294
201803 -3.333 105.290 -4.271
201806 -1.299 106.317 -1.649
201809 -3.616 106.507 -4.581
201812 0.757 105.998 0.964
201903 -3.186 107.251 -4.008
201906 -2.194 108.070 -2.739
201909 -3.825 108.329 -4.764
201912 -2.668 108.420 -3.320
202003 -1.942 108.902 -2.406
202006 12.998 108.767 16.124
202009 -1.697 109.815 -2.085
202012 0.698 109.897 0.857
202103 -2.780 111.754 -3.356
202106 -1.943 114.631 -2.287
202109 -1.357 115.734 -1.582
202112 -1.345 117.630 -1.543
202203 -2.566 121.301 -2.854
202206 -2.375 125.017 -2.563
202209 -2.228 125.227 -2.401
202212 -2.142 125.222 -2.308
202303 -1.821 127.348 -1.929
202306 -1.696 128.729 -1.778
202309 -2.775 129.860 -2.883
202312 -1.659 129.419 -1.730
202403 -0.439 131.776 -0.449
202406 -2.701 132.554 -2.749
202409 -1.718 133.029 -1.743
202412 -0.550 133.157 -0.557
202503 -0.490 134.927 -0.490

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


MEI Pharma  (LTS:0JW9) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


MEI Pharma Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of MEI Pharma's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


MEI Pharma Business Description

Industry
Traded in Other Exchanges
Address
9920 Pacific Heights Blvd, Suite 150, San Diego, CA, USA, 92121
MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

MEI Pharma Headlines

No Headlines